16474 Treatment response in ophiasis patients in a phase 2 trial of ATI-501 (an oral Janus kinase 1/3 inhibitor)
MacKay-Wiggan, Julian, Shanler, Stuart D., Moran, Susan, Cardillo, MarcoVolume:
83
Journal:
Journal of the American Academy of Dermatology
DOI:
10.1016/j.jaad.2020.06.346
Date:
December, 2020
File:
PDF, 229 KB
2020